## GEHC: GE HealthCare Technologies Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.8% below STRENGTH zone (3.0-6.0%); PEG 3.50 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 9, Bearish: 0)

**1. First Trust Advisors LP Has $61.43 Million Position in GE HealthCare Technologies Inc. $GEHC**
- Source: MarketBeat | 20251208T091252 | Somewhat-Bullish | Relevance: 98%
-  First Trust Advisors LP significantly increased its stake in GE HealthCare Technologies Inc., raising its position by 69.1% to 829,321 shares, valued at $61.43 million. This increase follows GE HealthCare's strong Q2 results, beating EPS and revenue estimates, and aligns with a "Moderate Buy" consensus rating from analysts with an average target price of $86.45. Other institutional investors have also adjusted their holdings in the company.

**2. 18,934 Shares in GE HealthCare Technologies Inc. $GEHC Bought by London & Capital Asset Management Ltd**
- Source: MarketBeat | 20251209T131728 | Bullish | Relevance: 98%
-  London & Capital Asset Management Ltd recently acquired 18,934 shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the second quarter, valued at approximately $1.4 million. Several other institutional investors have also adjusted their holdings in GEHC, indicating significant institutional interest. The company recently reported its quarterly earnings, beating analyst estimates, and announced a quarterly dividend.

**3. New Healthcare Leaders Emerge. 3 Stocks With Bullish Charts.**
- Source: Barron's | 20251209T160809 | Bullish | Relevance: 98%
-  Several non-biotech healthcare stocks like GE Healthcare, STERIS, and Hinge Health are showing strong momentum and technical setups, positioning them as leaders in the sector. These medical technology, services, and equipment stocks are exhibiting improving volume, accelerating relative strength, and clean technical patterns, suggesting continued upside. As investors pivot towards areas with sustained gains, these companies are expected to extend their momentum and deliver significant performance.

**4. AI-Powered Medical Devices Market Forecast Report 2025-2032: A Projected $59.8 Billion Industry Led by GE HealthCare Technologies, Siemens Healthineers, Philips, Canon Medical Systems, and Fujifilm - ResearchAndMarkets.com**
- Source: Business Wire | 20251209T150810 | Bullish | Relevance: 98%
- The AI-Powered Medical Devices Market is projected to reach $59.8 billion by 2032, growing at an 18.26% CAGR from $18.36 billion in 2025. This growth is driven by technological advancements, increasing adoption in clinical settings, and supportive reimbursement frameworks. Key players include GE HealthCare, Siemens Healthineers, and Philips, with AI integrating across all stages of device lifecycle to enhance diagnostics, monitoring, and treatment.

**5. New Healthcare Leaders Emerge. 3 Stocks With Bullish Charts.**
- Source: Barron's | 20251209T163409 | Bullish | Relevance: 98%
-  Several non-biotech healthcare stocks are showing significant momentum, breaking out of their bases and establishing themselves as sector leaders. With improving volume, accelerating relative strength, and clean technical setups, these medical technology, services, and equipment stocks are poised for continued strong performance. The article highlights GE Healthcare, STERIS, and Hinge Health.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | BTIG | $87 | $87 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | BTIG | reit | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.2%)
- Blackrock Inc.: 8.0% (+1.9%)
- Dodge & Cox Inc.: 6.0% (+16.8%)
- Capital Research Glo: 5.5% (+25.0%)
- State Street Corpora: 4.3% (-0.1%)

### Key Risks

1. Valuation stretched: PEG 3.5x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.50 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.9B |
| Beta | 1.24 |
| 52W Range | $57.65 - $94.80 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.50 |
| Forward P/E | 16.8 |
| Current P/E | 18.3 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.2% to 0.8% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.2pp (needs >3.0% for momentum thesis). MRS_5 (-0.8%) diverging from MRS_10 - short-term weakness emerging. Outperforming sector by 5.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.69), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.77% (CS: 65) | Neutral |
| RSI_14 | 62.8 | Neutral |
| MACD Histogram | 0.69 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 1.113x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $83.03
- **Stop Loss:** $78.53 (5.4% risk)
- **Target:** $87.53 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 66
- **Position Value:** $5,479.98
- **Portfolio %:** 5.48%
- **Risk Dollars:** $300.00
- **Risk Per Trade:** 0.30%
- **Modifiers:** L1 100% | L2 25% | Combined 0.30x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TOXIC (Zone G) | 0.25x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-12 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.05 | $1.07 | +2.2% |
| 2025Q2 | $0.92 | $1.06 | +15.4% |
| 2025Q1 | $0.91 | $1.01 | +10.6% |
| 2024Q4 | $1.26 | $1.45 | +14.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*